Viracta Therapeutics, Inc.

Viracta Therapeutics is a precision oncology company dedicated to developing novel treatments for virus-associated cancers. Their primary focus is on cancers linked to the Epstein-Barr Virus (EBV), a common infection present in over 90% of the world's population. Their lead product candidate, Nana-val, is an oral combination therapy utilizing their proprietary nanatinostat and the antiviral agent valganciclovir. This therapy is currently being evaluated in various clinical trials for treating a range of EBV-positive cancers, including lymphoma and nasopharyngeal carcinoma.

Viracta's "Kick and Kill" approach aims to effectively target EBV-infected cancer cells by reactivating the dormant virus, making it susceptible to antiviral treatment. The company boasts a strong team with extensive experience in drug development, and their commitment to innovation is reflected in their pursuit of orphan drug designations and fast track designations for Nana-val. Viracta is committed to improving the lives of patients battling virus-associated cancers, driving their efforts towards advancing new medicines and promoting patient well-being.

Viracta Therapeutics is a precision oncology company focused on developing novel treatments for virus-associated cancers, particularly those caused by the Epstein-Barr virus (EBV). Their mission is to advance new medicines that benefit patients with EBV-associated cancers and other serious diseases, utilizing a unique "Kick and Kill" approach. Their lead product candidate, Nana-val, is an all-oral combination therapy currently in clinical trials for various EBV+ malignancies, including lymphomas and nasopharyngeal carcinoma.

Viracta Therapeutics fosters a collaborative and supportive culture that prioritizes innovation and a shared commitment to improving the lives of cancer patients. The company emphasizes teamwork, celebrates individual achievements, and empowers employees to make a difference in the fight against virus-associated cancers.

Viracta Therapeutics, Inc. is committed to fostering a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and empowered to contribute their unique talents and perspectives. The company embraces a culture of belonging, where individuals from all backgrounds are encouraged to share their ideas, experiences, and insights. This commitment is reflected in the company's efforts to recruit, develop, and retain a diverse workforce, provide equal opportunities for advancement, and create a welcoming and supportive environment for all employees.